Leadership Announcements and New Arcera Structure
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
Report underscores Acino’s continued commitment to Environmental, Social, and Governance goals, including a firm commitment to reaching full carbon neutrality...
Acino reaffirms its commitment to advancing cardiovascular health in emerging markets and beyond.
Acino will market, commercialize, and distribute Hyruan One® in Brazil, and Zemiglo® and Zemimet® SR (Zemiduo® SR in Mexico) in...
We have expanded our portfolio with several novel products, marking a significant step forward in our effort to help more...
Acino will collaborate with Supernus to develop and commercialize products for the treatment of diseases of the central nervous system...
Joel Barlan has been appointed as Head of the LATAM region. Mexico City will now serve as a regional hub...
We are collaborating to bring an important orphan drug for cancer patients to Latin America.
Acino will enhance its presence in Latin America and strengthen its business through new partnerships, innovative and proven portfolio and...